الرسائل الموجهة للمختصين الصحيين

Cases of Necrotizing Fasciitis Reported with AVASTIN  ​

Risk of Toxic Epidermal Necrolysis And Stevens-Johnson-Syndrome  ​​

Risk of (PAH) Pulmonary Arterial Hypertension ​​

Risk of hepatotoxicity with agomelatine  ​​

Risk of hepatotoxicity

Risk of serious birth defects  ​

Increased risk of congenital cardiovascular malformations ​​

Cardiovascular adverse events after the first dose of Gilenya®  ​​

Risk of developing abnormal changes in the electrical activity of the heart ​​

Reports of severe infectious endophthalmitis following unapproved intravitreal injection use ​

Risk of bladder cancer ​